Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Castor

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Biochemistry|May 1, 1990
A possible receptor-binding function for the N-terminus of connective tissue activating peptide IIIJ Erickson, L E Davis, C W Castor, et al.
Methods in Enzymology|January 1, 1991
Preparation and bioassay of connective tissue activating peptide III and its isoformsC W Castor, E M Smith, M C Bignall, et al.
The Journal of Rheumatology|May 1, 1987
Anabolic and catabolic responses of human articular cells to growth factorsC W Castor, C G Ragsdale, A R Cabral, et al.
The Journal of Biological Chemistry|September 25, 1992
Regulation of glucose transporters by connective tissue activating peptide-III isoformsP K Tai, J F Liao, P A Hossler, et al.
Arthritis and Rheumatism|July 1, 1992
Connective tissue activation. XXXV. Detection of connective tissue activating peptide-III isoforms in synovium from osteoarthritis and rheumatoid arthritis patients: patterns of interaction with other synovial cytokines in cell cultureC W Castor, E M Smith, P A Hossler, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|July 1, 1980
Connective tissue activation. XVI. Detection of a human platelet-derived connective tissue activating peptide (CTAP-III) in human sera and plasma and in synovial fluids and tissuesT B Sloan, J J Weiss, B Anderson, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|July 1, 1977
Characteristics of an antigen reactivity in synovial fluids and its association with rheumatoid arthritisA Jameson, M L Steffes, R Martincic, et al.
Annals of Clinical and Laboratory Science|May 1, 1982
Fibronectin in rheumatoid and non-rheumatoid arthritic synovial fluids and in synovial fluid cryoproteinsM Lu-Steffes, A J Iammartino, F R Schmid, et al.
The Journal of Rheumatology|June 1, 1985
Measurement of exercise tolerance in patients with rheumatoid arthritis and osteoarthritisC A Beals, R M Lampman, B F Banwell, et al.
The Journal of Allergy and Clinical Immunology|March 1, 1992
Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophilsS R Reddigari, P Kuna, G F Miragliotta, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Biochemistry|May 1, 1990
A possible receptor-binding function for the N-terminus of connective tissue activating peptide IIIJ Erickson, L E Davis, C W Castor, et al.
Methods in Enzymology|January 1, 1991
Preparation and bioassay of connective tissue activating peptide III and its isoformsC W Castor, E M Smith, M C Bignall, et al.
The Journal of Rheumatology|May 1, 1987
Anabolic and catabolic responses of human articular cells to growth factorsC W Castor, C G Ragsdale, A R Cabral, et al.
The Journal of Biological Chemistry|September 25, 1992
Regulation of glucose transporters by connective tissue activating peptide-III isoformsP K Tai, J F Liao, P A Hossler, et al.
Arthritis and Rheumatism|July 1, 1992
Connective tissue activation. XXXV. Detection of connective tissue activating peptide-III isoforms in synovium from osteoarthritis and rheumatoid arthritis patients: patterns of interaction with other synovial cytokines in cell cultureC W Castor, E M Smith, P A Hossler, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|July 1, 1980
Connective tissue activation. XVI. Detection of a human platelet-derived connective tissue activating peptide (CTAP-III) in human sera and plasma and in synovial fluids and tissuesT B Sloan, J J Weiss, B Anderson, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|July 1, 1977
Characteristics of an antigen reactivity in synovial fluids and its association with rheumatoid arthritisA Jameson, M L Steffes, R Martincic, et al.
Annals of Clinical and Laboratory Science|May 1, 1982
Fibronectin in rheumatoid and non-rheumatoid arthritic synovial fluids and in synovial fluid cryoproteinsM Lu-Steffes, A J Iammartino, F R Schmid, et al.
The Journal of Rheumatology|June 1, 1985
Measurement of exercise tolerance in patients with rheumatoid arthritis and osteoarthritisC A Beals, R M Lampman, B F Banwell, et al.
The Journal of Allergy and Clinical Immunology|March 1, 1992
Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophilsS R Reddigari, P Kuna, G F Miragliotta, et al.
Pageof 8